Purinergic P2X7 receptor antagonists: Chemistry and fundamentals of biological screening

被引：11
|
作者：
Gunosewoyo, Hendra [1 ,2 ]
Coster, Mark J. [3 ]
Bennett, Maxwell R. [2 ]
Kassiou, Michael [1 ,2 ,4 ]
机构：
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Brain & Mind Res Inst, Sydney, NSW 2050, Australia
[3] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia
[4] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 14期
关键词：
P2X7; antagonists; Cytokine release; Rational drug design; LL-37; IN-VITRO ACTIVITY; INTERLEUKIN-1-BETA RELEASE; POLYMYXIN-B; POTENT; DISCOVERY; PEPTIDE; LL-37; PAIN; TAIL;
D O I：
10.1016/j.bmc.2009.05.083
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The purinergic P2X(7) receptor is a unique member of the ATP-gated P2X family. This receptor has been implicated in numerous diseases and many structurally diverse ligands have been discovered via high throughput screening. This perspective will attempt to highlight some of the most recent key findings in both the biology and chemistry. (C) 2009 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码：4861 / 4865
页数：5
相关论文
共 50 条
  • [1] From tyrosine to glycine:: Synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Carrion, Maria Dora
    Cara, Carlota Lopez
    Preti, Delia
    Cruz-Lopez, Olga
    Tabrizi, Mojgan Aghazadeh
    Moorman, Allan R.
    Gessi, Stefania
    Fogli, Eleonora
    Sacchetto, Valeria
    Borea, Pier Andrea
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (15) : 3706 - 3715
  • [2] Radioligands targeting purinergic P2X7 receptor
    Zheng, Qi-Huang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (12)
  • [3] The role of the purinergic P2X7 receptor in inflammation
    Lister M.F.
    Sharkey J.
    Sawatzky D.A.
    Hodgkiss J.P.
    Davidson D.J.
    Rossi A.G.
    Finlayson K.
    Journal of Inflammation, 4 (1)
  • [4] P2X7 purinergic receptor and osteoclast formation
    Hiken, JF
    Atal, N
    Steinberg, TH
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 255A - 255A
  • [5] Novel P2X7 receptor antagonists
    Alcaraz, L
    Baxter, A
    Bent, J
    Bowers, K
    Braddock, M
    Cladingboel, D
    Donald, D
    Fagura, M
    Furber, M
    Laurent, C
    Lawson, M
    Mortimore, M
    McCormick, M
    Roberts, N
    Robertson, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 4043 - 4046
  • [6] Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists
    El Idrissi, Imane Ghafir
    Podlewska, Sabina
    Abate, Carmen
    Bojarski, Andrzej J.
    Lacivita, Enza
    Leopoldo, Marcello
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (11) : 1361 - 1403
  • [7] The P2X7 purinergic receptor in intervertebral disc degeneration
    Penolazzi, Letizia
    Bergamin, Leticia S.
    Lambertini, Elisabetta
    Poma, Valentina V.
    Sarti, Alba C.
    De Bonis, Pasquale
    Di Virgilio, Francesco
    Piva, Roberta
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (02) : 1418 - 1428
  • [8] Mitochondrial Localization and Function of the Purinergic Receptor P2X7
    Kroemer, Guido
    Verkhratsky, Alexei
    FUNCTION, 2021, 2 (02):
  • [9] The role of the purinergic receptor p2x7 in the pathogenesis of atherosclerosis
    Merz, J.
    Heidenreich, A.
    Stachon, P.
    Bode, C.
    Zirlik, A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 853 - 853
  • [10] Novel P2X7 receptor antagonists.
    Alcaraz, L
    Bent, J
    Bowers, K
    Donald, D
    Fagura, M
    Furber, M
    Laurent, C
    Lawson, M
    Mortimore, M
    McCormick, M
    Robertson, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U45 - U45
12345